| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Intellia Therapeutics, Inc. (NTLA) has 12 insiders with recent SEC Form 4 filings, including 2 buys and 11 sells. NTLA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.01M | $12.27M | - | |
| Dir | 207.5K | $2.51M | - | |
| Dir | 134.7K | $1.63M | - | |
| VP | 121.2K | $1.47M | - | |
| VP | 101.5K | $1.23M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2020 | Rivera Jose E | EVP, General Counsel | Sale+OE | 5,615 | $21.00 | $117,915.00 | -15.0% | |
| Aug 6, 2020 | Leonard John M.83 | President And CEO | Sale+OE | 5,000 | $21.83 | $109,150.00 | -1.1% | |
| Jul 15, 2020 | Rivera Jose E | EVP, General Counsel | Sale+OE | 5,615 | $22.70 | $127,460.50 | -16.9% | |
| Jul 1, 2020 | Leonard John M.83 | President And CEO | Sale+OE | 5,000 | $21.83 | $109,150.00 | -1.1% | |
| Jun 16, 2020 | Rivera Jose E | EVP, General Counsel | Sale+OE | 5,615 | $21.00 | $117,915.00 | -20.1% | |
| Jun 3, 2020 | Leonard John M.83 | President And CEO | Sale+OE | 5,000 | $21.83 | $109,150.00 | -1.1% | |
| May 26, 2020 | Rivera Jose E | EVP, General Counsel | Sale+OE | 5,615 | $21.21 | $119,094.15 | -2.0% | |
| Mar 6, 2019 | Schiermeier Andrew | EVP, Dev And Corp Strategy | Buy | 7,500 | $15.72 | $117,875.00 | +230.8% | |
| Jul 16, 2018 | Formela Jean Francois70 | Director | Sell | 6,686 | $31.17 | $208,397.27 | -82.7% | |
| Jun 19, 2018 | Formela Jean Francois70 | Director | Sell | 6,686 | $27.96 | $186,908.24 | -82.7% |